Virtus ETF Advisers LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 80 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2020$80,000
-81.2%
44,601
-12.0%
0.04%
-79.1%
Q2 2020$425,000
+13.6%
50,694
-28.9%
0.20%
+30.5%
Q1 2020$374,000
-16.1%
71,343
-12.7%
0.15%
+111.0%
Q4 2019$446,000
+147.8%
81,751
+121.7%
0.07%
+102.8%
Q3 2019$180,000
-33.3%
36,881
-5.3%
0.04%
-36.8%
Q2 2019$270,000
-4.3%
38,935
-4.2%
0.06%
-90.5%
Q1 2019$282,000
+4.8%
40,628
-12.0%
0.60%
+1204.3%
Q4 2018$269,000
-54.0%
46,147
-40.4%
0.05%
-23.3%
Q3 2018$585,000
-12.8%
77,428
-41.7%
0.06%
-89.9%
Q2 2018$671,000
+7.4%
132,890
+29.7%
0.59%
+9.4%
Q1 2018$625,000
+85.5%
102,493
+116.1%
0.54%
+28.1%
Q4 2017$337,000
-15.8%
47,426
-15.2%
0.42%
+683.3%
Q3 2017$400,000
+25.0%
55,909
+10.1%
0.05%
+12.5%
Q2 2017$320,000
+19.4%
50,795
+56.1%
0.05%0.0%
Q1 2017$268,000
+7.6%
32,545
+10.6%
0.05%
-35.1%
Q4 2016$249,00029,4250.07%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$42,335,00024.44%
MANGROVE PARTNERS IM, LLC 552,200$4,633,0001.13%
ETF MANAGERS GROUP, LLC 3,707,912$31,109,0001.10%
Ikarian Capital, LLC 1,350,000$11,327,0000.90%
GENERAL AMERICAN INVESTORS CO INC 712,400$5,977,0000.76%
AdvisorShares Investments LLC 189,814$1,593,0000.68%
Ikarian Capital, LLC 1,000,000$8,390,0000.67%
Granite Point Capital Management, L.P. 1,123,600$9,427,0000.48%
Carmignac Gestion 3,773,440$31,659,0000.44%
Omnia Family Wealth, LLC 32,356$271,467,0000.27%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders